Semax (ACTH Fragment Peptide)

A Mechanism Layer Below Gene Expression

UKPWritten and published by UK Peptides2 min readUpdated 2 cited sources

The short answer

Kolbaev and colleagues examined the effect of Semax on intracellular calcium dynamics in rat brain neurons, published in the Bulletin of Experimental Biology and Medicine in August 2025. This is a different and faster level of mechanism than the neurotrophin expression literature.

Key facts

Study
Kolbaev 2025 (PMID 41171324)
Journal
Bull Exp Biol Med, August 2025
Preparation
Rat brain neurons
Measured
Intracellular calcium dynamics
Timescale
Seconds to minutes
Contrast
Gene expression acts over hours

Why calcium is a useful readout

Intracellular calcium concentration is one of the most general signalling variables a neuron has. It changes within seconds of a stimulus, it is measurable in living cells with fluorescent indicators, and it sits upstream of a great many downstream processes. A compound that alters calcium dynamics is doing something at the level of immediate cell signalling.

Why this differs from the neurotrophin work

The existing Semax literature centres on expression of neurotrophins such as BDNF and NGF, a transcriptional readout operating over hours. Calcium operates over seconds. These are not competing accounts; they are different levels of a potential causal chain, and a fast signalling event is the kind of thing that could sit upstream of a slower transcriptional one.

Research material referenced

Semax 10mg, third-party HPLC tested

Buy Semax · £24.99

Why a fast readout is analytically valuable

Expression changes measured hours after exposure leave a long interval in which many things could intervene. An effect appearing within seconds in isolated neurons is much harder to attribute to anything other than the compound present, which narrows the causal question considerably even without identifying a receptor.

What it does not establish

A receptor, or a behavioural consequence. Altered calcium dynamics in rat brain neurons is a cellular observation. Semax still has no identified receptor, and a calcium effect is compatible with several mechanisms including indirect ones. It narrows the question rather than answering it.

Where the publication sits

The Bulletin of Experimental Biology and Medicine is a Russian journal, and the Semax literature is substantially Russian in origin, a point the existing literature article on this site makes. That is context for interpretation rather than a dismissal: the language and location of publication are not measures of quality, and limited independent replication outside that tradition is a real and separate limitation.

Regulatory position

Semax holds no marketing authorisation from the MHRA, EMA or FDA. Registration in another jurisdiction does not alter that, and material supplied here is for laboratory research only with no claim about any effect in any person.

Frequently asked questions

What did the 2025 study measure?

Intracellular calcium dynamics in rat brain neurons following Semax exposure, which is a cellular signalling readout.

How does that relate to the BDNF work?

Different timescales. Calcium changes within seconds; gene expression over hours. A fast event could sit upstream of a slower transcriptional one.

Does it identify a receptor?

No. Semax still has no identified receptor, and a calcium effect is compatible with several mechanisms including indirect ones.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More Semax (ACTH Fragment Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.